Ha Tay Pharmaceutical JSC (HNX:DHT)

Market Cap	7.42T
Revenue (ttm)	2.09T
Net Income (ttm)	71.77B
Shares Out	82.34M
EPS (ttm)	871.65
PE Ratio	103.37
Forward PE	n/a
Dividend	1,000.00 (1.11%)
Ex-Dividend Date	Oct 30, 2024

Volume	115,069
Average Volume	46,537
Open	87,100
Previous Close	87,000
Day's Range	87,100 - 93,000
52-Week Range	22,600 - 110,900
Beta	0.47
RSI	60.17
Earnings Date	Apr 25, 2025

About Ha Tay Pharmaceutical JSC

Ha Tay Pharmaceutical JSC manufactures, trades in, imports, and exports medicines, chemical raw materials for medicine, medicinal materials, and medical equipment. It offers functional foods and drugs. In addition, the company provides medicinal products manufacturing services; and import-export authorization services, as well as supplies pharmaceutical ingredients for enterprises. The company was founded in 1965 and is based in Hanoi, Vietnam.

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Country: Vietnam
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: DHT

Financial Performance

In 2024, Ha Tay Pharmaceutical JSC's revenue was 2.09 trillion, an increase of 4.35% compared to the previous year's 2.00 trillion. Earnings were 71.77 billion, a decrease of -15.62%.